| 5-R01-EB033677-07 |
A “STICK” theranostic nanoplatform for image-guided drug delivery to brain malignancies |
Yuanpei Li |
University of California at Davis |
| 5-R01-EB027078-04 |
Active Drug Loading to Nanovesicles for Targeted Drug Delivery |
Zhenjia Wang |
Washington State University |
| 4-R00-EB028838-03 |
Anti-biofilm laser-mediated photothermal ablation via complex noble metal nanostructures |
Maryam Hajfathalian |
New Jersey Institute of Technology |
| 5-R21-EB034443-02 |
Computational Design of Antibody-Drug-Excipient Nanoparticles |
Daniel Reker |
Duke University |
| 5-R01-EB026893-05 |
Controllable In Vivo Genome Editing for Immune-Checkpoint Blockade in Solid Tumors |
Sheng Tong |
University of Kentucky |
| 1-R21-EB034465-01 |
Designing a targeted 'super adjuvant' nanoparticle platform for vaccination |
Prabhani Atukorale |
University of Massachusetts Amherst |
| 5-R01-EB028534-04 |
Developing nanoplexes for RNAi-expressing plasmids |
Archibald Mixson |
University of Maryland Baltimore |
| 5-R01-EB031022-03 |
Development of a web-based predictive model of nanoparticle delivery to tumors by integrating physiologically-based pharmacokinetic modeling with artificial intelligence |
Zhoumeng Lin |
University of Florida |
| 5-R03-EB032579-02 |
Development of Sulfonium- and Phosphonium-based Cationic Lipid Materials for mRNA Delivery |
Yamin Li |
Upstate Medical University |
| 5-R21-EB033687-02 |
Engineered immunotherapies neutralizing interleukin-22 binding protein |
Joel Collier |
Duke University |
